Latest News

Commercialization

ACTSI-supported Start-up Update: NeurOp

Created in 2007 as one of a national consortium striving to improve the way biomedical research is conducted across the country, the Atlanta Clinical & Translational Science Institute (ACTSI) works to break down obstacles in the translational...

Community

Science Advance: Association Between Living in Food Deserts & Cardiovascular Risk, an Atlanta Study

Several Georgia CTSA-supported researchers used existing data from Georgia CTSA’s Center for Health Discovery & Well Being and the Morehouse and Emory Team up to Eliminate Health Disparities (META)-Health Study to build a cohort of...

Discovery

CTSA Offers Study Design for Belatacept Clinical Trial

ACTSI's biostatistics program developed an optimal three-stage group sequential design for monitoring the safety of the clinical trial Bela 8 Week Dosing. The trial is examining immunosuppression therapy in post-transplant kidney recipients and is...

Discovery

Georgia Clinical & Translational Science Alliance receives $51 million NIH state-wide grant

After a decade of research collaboration, the Atlanta Clinical & Translational Science Institute (ACTSI) will welcome a new partner and change its name, reflecting a new statewide focus. The University of Georgia will officially become the...

Discovery

Emory i2b2 Update

Georgia CTSA has updated Emory i2b2 to version 1.7.08a. Emory I2b2 is a study feasibility assessment tool that lets you quickly determine how many Emory Healthcare patients might be eligible for your planned study, and how different inclusion and...

Community

Update: Translation to Practice of an Intervention to Promote Colorectal Cancer Screening Among African Americans

The Georgia CTSA-supported Colorectal Cancer Screening Intervention Program (CCSIP) was recently featured on the NIH National Cancer Institute’s Division of Cancer Control & Populations Sciences’ Research to Reality. The...

Upcoming Events

View All Events